US5254582AExpiredUtility
Antitumor compositions and methods
Est. expiryFeb 5, 2012(expired)· nominal 20-yr term from priority
Inventors:George B. BoderWilliam J. EhlhardtGerald B. GrindeyJohn E. TothJohn F. WorzallaJohn L. Zimmermann
C07D 307/79A61P 35/00C07D 307/77
61
PatentIndex Score
9
Cited by
36
References
3
Claims
Abstract
This invention provides the use of N-[[(3,4-dichlorophenyl)amino]carbonyl]-2,3-dihydrobenzofuran-5-sulfonamide, and pharmaceutically acceptable salts thereof, in the treatment of susceptible neoplasms in mammals. This invention further provides the novel aforementioned compound and its pharmaceutical formulations.
Claims
exact text as granted — not AI-modifiedWe claim:
1. A method of treating susceptible neoplasms in mammals which comprises administering to a mammal in need of said treatment an effective amount for treating susceptible neoplasms of a compound of the formula ##STR7## or a pharmaceutically acceptable salt thereof.
2. A compound of the formula ##STR8## and pharmaceutically acceptable salts thereof.
3. A pharmaceutical formulation comprising an effective amount of a compound of the formula ##STR9## or a pharmaceutically acceptable salt thereof, in combination with a suitable pharmaceutical excipient.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.